https://ashpublications.org/blood/article/126/23/2810/135333/A-Phase-2-Study-to-Evaluate-the-Efficacy-and
This is concerning a trial where LOXL2 didn’t reliably reduce bone marrow fibrosis.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.002(3.45%) |
Mkt cap ! $90.99M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.9¢ | 5.6¢ | $163.1K | 2.878M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 199860 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 134617 | 5 |
View Market Depth
| Last trade - 15.32pm 18/06/2025 (20 minute delay) ? |
| SNT (ASX) Chart |